Codes J7509 to J9274
Page 5 of 6 of the hub's 847 codes, in code order: 148 codes on this page have an indexed reference page and are in the table, and the other 7 are listed as text below it.
| Code | Descriptor | Unit | Limit | MUE | Col-2 pairs | Articles |
|---|---|---|---|---|---|---|
| J7509 | Methylprednisolone oral, per 4 mg | 4 MG | $0.128 | 0 | — | — |
| J7510 | Prednisolone oral, per 5 mg | 5 MG | $0.498 | 0 | — | — |
| J7511 | Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg | 25 MG | $1,065.837 | 9 | — | — |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1 MG | $0.004 | 0 | — | — |
| J7515 | Cyclosporine, oral, 25 mg | 25 MG | $0.576 | 0 | — | — |
| J7516 | Injection, cyclosporine, 250 mg | 250 MG | $75.649 | 1 | — | — |
| J7518 | Mycophenolic acid, oral, 180 mg | 180 MG | $0.257 | 0 | — | — |
| J7520 | Sirolimus, oral, 1 mg | 1 MG | $0.609 | 0 | — | — |
| J7521 | Tacrolimus, granules, oral suspension, 0.1 mg | 0.1 MG | $1.328 | 300 | — | — |
| J7525 | Tacrolimus, parenteral, 5 mg | 5 MG | $242.073 | 2 | — | — |
| J7527 | Everolimus, oral, 0.25 mg | 0.25 MG | $1.126 | 40 | — | — |
| J7601 | Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg | 3 MG | $52.117 | 2 | — | — |
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | 15 mcg | $0.542 | 2 | — | — |
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms | 20 MCG | $1.373 | 2 | — | — |
| J7608 | Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram | 1 GM | $6.398 | 3 | — | — |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 1 MG | $0.206 | 10 | — | — |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | 0.5 MG | $0.304 | 10 | — | — |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 1 MG | $0.066 | 10 | — | — |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | 0.5 MG | $0.076 | 10 | — | — |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 2.5 MG/0.5 MG | $0.197 | 6 | — | — |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 0.5 MG | $0.923 | 2 | — | — |
| J7631 | Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams | 10 MG | $0.385 | 4 | — | — |
| J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 1 MG | $56.806 | 3 | — | — |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 1 MG | $0.445 | 3 | — | — |
| J7674 | Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg | 1 MG | $1.766 | 100 | — | — |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram | 1 MCG | $0.20 | 175 | — | — |
| J7682 | Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams | 300 MG | $11.404 | 2 | — | — |
| J7686 | Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg | 1.74 MG | $830.383 | 1 | — | — |
| J8501 | Aprepitant, oral, 5 mg | 5 MG | $2.511 | 0 | — | — |
| J8502 | Injection, aprepitant (aponvie), 1 mg | 1 MG | $1.998 | — | — | — |
| J8510 | Busulfan; oral, 2 mg | 2 mg | $10.12 OPPS | 0 | — | — |
| J8515 | Cabergoline, oral, 0.25 mg | 0.25 MG | $0.337 | 0 | — | — |
| J8522 | Capecitabine, oral, 50 mg | 50 MG | $0.029 | — | — | — |
| J8530 | Cyclophosphamide; oral, 25 mg | 25 MG | $1.233 | 0 | — | — |
| J8540 | Dexamethasone, oral, 0.25 mg | 0.25 MG | $0.022 | 0 | — | — |
| J8541 | Dexamethasone (hemady), oral, 0.25 mg | 0.25 MG | $0.375 | — | — | — |
| J8560 | Etoposide; oral, 50 mg | 50 MG | $88.164 | 0 | — | — |
| J8610 | Methotrexate; oral, 2.5 mg | 2.5 MG | $0.157 | 0 | — | — |
| J8611 | Methotrexate (jylamvo), oral, 2.5 mg | 2.5 MG | $18.264 | — | — | — |
| J8612 | Methotrexate (xatmep), oral, 2.5 mg | 2.5 MG | $22.855 | — | — | — |
| J8655 | Netupitant 300 mg and palonosetron 0.5 mg, oral | 0.5 MG | $455.762 | 1 | — | — |
| J8700 | Temozolomide, oral, 5 mg | 5 MG | $0.208 | 0 | — | — |
| J8705 | Topotecan, oral, 0.25 mg | 0.25 mg | $125.461 | 0 | — | — |
| J9000 | Injection, doxorubicin hydrochloride, 10 mg | 10 MG | $3.12 | 20 | — | — |
| J9011 | Injection, datopotamab deruxtecan-dlnk, 1 mg | 1 MG | $52.505 | 600 | — | — |
| J9015 | Injection, aldesleukin, per single use vial | $3,338.87 OPPS | 1 | — | — | |
| J9017 | Injection, arsenic trioxide, 1 mg | 1 MG | $3.837 | 30 | — | — |
| J9021 | Injection, asparaginase, recombinant, (rylaze), 0.1 mg | 0.1 MG | $59.042 | 1500 | — | — |
| J9022 | Injection, atezolizumab, 10 mg | 10 MG | $96.873 | 168 | — | — |
| J9023 | Injection, avelumab, 10 mg | 10 MG | $108.994 | 140 | — | — |
| J9024 | Injection, atezolizumab, 5 mg and hyaluronidase-tqjs | 5 MG | $32.419 | 375 | — | — |
| J9025 | Injection, azacitidine, 1 mg | 1 MG | $0.269 | 300 | — | — |
| J9026 | Injection, tarlatamab-dlle, 1 mg | 1 MG | $1,613.751 | 10 | — | — |
| J9027 | Injection, clofarabine, 1 mg | 1 MG | $15.518 | 100 | — | — |
| J9028 | Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram | 1 MCG | $94.139 | 400 | — | — |
| J9029 | Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose | PER THERAPEUTIC DOSE | $65,200.563 | 1 | — | — |
| J9030 | Bcg live intravesical instillation, 1 mg | 1 MG | $3.532 | 50 | — | yes |
| J9032 | Injection, belinostat, 10 mg | 10 MG | $55.526 | 300 | — | — |
| J9033 | Injection, bendamustine hydrochloride, not otherwise specified, 1 mg | 1 MG | $1.846 | 300 | — | — |
| J9034 | Injection, bendamustine hcl (bendeka), 1 mg | 1 MG | $11.422 | 360 | — | — |
| J9035 | Injection, bevacizumab, 10 mg | 10 MG | $75.492 | 230 | — | yes |
| J9036 | Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg | 1 MG | $9.264 | 360 | — | — |
| J9038 | Injection, axatilimab-csfr, 0.1 mg | 0.1 MG | $56.498 | 360 | — | — |
| J9039 | Injection, blinatumomab, 1 microgram | 1 MCG | $173.047 | 210 | — | — |
| J9040 | Injection, bleomycin sulfate, 15 units | 15 UNITS | $23.12 | 4 | — | — |
| J9041 | Injection, bortezomib, 0.1 mg | 0.1 MG | $2.628 | 35 | — | — |
| J9042 | Injection, brentuximab vedotin, 1 mg | 1 MG | $279.207 | 200 | — | — |
| J9043 | Injection, cabazitaxel, 1 mg | 1 MG | $231.688 | 60 | — | — |
| J9045 | Injection, carboplatin, 50 mg | 50 MG | $3.101 | 22 | — | — |
| J9046 | Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg | 0.1 mg | $3.46 OPPS | 35 | — | — |
| J9047 | Injection, carfilzomib, 1 mg | 1 MG | $60.391 | 210 | — | — |
| J9049 | Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg | 0.1 MG | $1.531 | 35 | — | — |
| J9050 | Injection, carmustine, 100 mg | 100 MG | $195.73 | 6 | — | — |
| J9053 | Injection, belantamab mafodotin-blmf, 0.1 mg | 0.1 MG | $36.201 | — | — | — |
| J9054 | Injection, bortezomib (boruzu), 0.1 mg | 0.1 MG | $23.905 | 70 | — | — |
| J9055 | Injection, cetuximab, 10 mg | 10 MG | $80.858 | 150 | — | — |
| J9056 | Injection, bendamustine hydrochloride (vivimusta), 1 mg | 1 MG | $28.614 | 360 | — | — |
| J9060 | Injection, cisplatin, powder or solution, 10 mg | 10 MG | $2.497 | 24 | — | — |
| J9061 | Injection, amivantamab-vmjw, 2 mg | 2 MG | $23.622 | 1050 | — | — |
| J9062 | Injection, amivantamab 5 mg and hyaluronidase-lpuj | 5 MG | $40.492 | — | — | — |
| J9063 | Injection, mirvetuximab soravtansine-gynx, 1 mg | 1 MG | $71.584 | 900 | — | — |
| J9065 | Injection, cladribine, per 1 mg | 1 MG | $7.872 | 100 | — | — |
| J9071 | Injection, cyclophosphamide (auromedics), 5 mg | 5 MG | $0.471 | 1500 | — | — |
| J9072 | Injection, cyclophosphamide (frindovyx), 5 mg | 5 MG | $8.12 | 1500 | — | — |
| J9073 | Injection, cyclophosphamide (dr. reddy's), 5 mg | 5 MG | $0.465 | 1500 | — | — |
| J9074 | Injection, cyclophosphamide (sandoz), 5 mg | 5 MG | $3.238 | 1500 | — | — |
| J9075 | Injection, cyclophosphamide, not otherwise specified, 5 mg | 5 MG | $0.692 | 1500 | — | — |
| J9076 | Injection, cyclophosphamide (baxter), 5 mg | 5 MG | $4.601 | 1500 | — | — |
| J9100 | Injection, cytarabine, 100 mg | 100 MG | $0.853 | 120 | — | — |
| J9118 | Injection, calaspargase pegol-mknl, 10 units | 10 UNIT | $86.179 | 750 | — | — |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 1 MG | $30.825 | 700 | — | — |
| J9120 | Injection, dactinomycin, 0.5 mg | 0.5 MG | $320.899 | 5 | — | — |
| J9130 | Dacarbazine, 100 mg | 100 MG | $3.581 | 24 | — | — |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 10 MG | $57.973 | 180 | — | — |
| J9145 | Injection, daratumumab, 10 mg | 10 MG | $75.228 | 240 | — | — |
| J9150 | Injection, daunorubicin, 10 mg | 10 MG | $26.912 | 12 | — | — |
| J9153 | Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine | 1 MG/2.27 MG | $274.30 | 132 | — | — |
| J9155 | Injection, degarelix, 1 mg | 1 MG | $4.509 | 240 | — | — |
| J9161 | Injection, denileukin diftitox-cxdl, 1 mcg | 1 MCG | $12.826 | 1500 | — | — |
| J9171 | Injection, docetaxel, 1 mg | 1 MG | $0.471 | 300 | — | — |
| J9172 | Injection, docetaxel (docivyx), 1 mg | 1 MG | $46.193 | 300 | — | — |
| J9173 | Injection, durvalumab, 10 mg | 10 MG | $87.658 | 150 | — | — |
| J9174 | Injection, docetaxel (beizray), 1 mg | 1 MG | $46.531 | 320 | — | — |
| J9176 | Injection, elotuzumab, 1 mg | 1 MG | $8.188 | 3000 | — | — |
| J9177 | Injection, enfortumab vedotin-ejfv, 0.25 mg | 0.25 MG | $36.535 | 520 | — | — |
| J9178 | Injection, epirubicin hcl, 2 mg | 2 MG | $1.868 | 150 | — | — |
| J9179 | Injection, eribulin mesylate, 0.1 mg | 0.1 MG | $63.972 | 50 | — | — |
| J9183 | Gemcitabine intravesical system, 225 mg | 225 MG | $73,054.053 | — | — | — |
| J9184 | Injection, gemcitabine hydrochloride (avyxa), 200 mg | 200 MG | $403.465 | 19 | — | — |
| J9185 | Injection, fludarabine phosphate, 50 mg | 50 MG | $177.924 | 2 | — | — |
| J9186 | Injection, etoposide (avyxa), 1 mg | 1 MG | $4.24 | — | — | — |
| J9191 | Injection, fluorouracil (avyxa), 10 mg | 10 MG | $14.84 | — | — | — |
| J9200 | Injection, floxuridine, 500 mg | 500 MG | $4,389.848 | 5 | — | yes |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 200 MG | $2.734 | 20 | — | — |
| J9203 | Injection, gemtuzumab ozogamicin, 0.1 mg | 0.1 MG | $247.37 | 180 | — | — |
| J9204 | Injection, mogamulizumab-kpkc, 1 mg | 1 MG | $258.536 | 160 | — | — |
| J9205 | Injection, irinotecan liposome, 1 mg | 1 MG | $66.856 | 215 | — | — |
| J9206 | Injection, irinotecan, 20 mg | 20 MG | $1.569 | 42 | — | — |
| J9207 | Injection, ixabepilone, 1 mg | 1 MG | $139.498 | 90 | — | — |
| J9208 | Injection, ifosfamide, 1 gram | 1 GM | $27.905 | 15 | — | — |
| J9209 | Injection, mesna, 200 mg | 200 MG | $1.203 | 55 | — | — |
| J9210 | Injection, emapalumab-lzsg, 1 mg | 1 MG | $391.861 | 1500 | — | — |
| J9211 | Injection, idarubicin hydrochloride, 5 mg | 5 MG | $33.394 | 6 | — | — |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 7.5 MG | $188.849 | 6 | — | yes |
| J9220 | Injection, indigotindisulfonate sodium, 1 mg | 1 MG | $8.151 OPPS | 40 | — | — |
| J9223 | Injection, lurbinectedin, 0.1 mg | 0.1 MG | $215.722 | 120 | — | — |
| J9226 | Histrelin implant (supprelin la), 50 mg | 50 MG | $37,837.548 | 1 | — | — |
| J9227 | Injection, isatuximab-irfc, 10 mg | 10 MG | $89.812 | 150 | — | — |
| J9228 | Injection, ipilimumab, 1 mg | 1 MG | $190.433 | 1100 | — | — |
| J9229 | Injection, inotuzumab ozogamicin, 0.1 mg | 0.1 MG | $2,873.103 | 27 | — | — |
| J9232 | Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg | 1 MG | $0.513 | — | — | — |
| J9245 | Injection, melphalan hydrochloride, not otherwise specified, 50 mg | 50 MG | $90.032 | 9 | — | — |
| J9246 | Injection, melphalan (evomela), 1 mg | 1 MG | $18.569 | 300 | — | — |
| J9248 | Injection, melphalan (hepzato), 1 mg | 1 MG | $797.415 | 250 | — | — |
| J9249 | Injection, melphalan (apotex), 1 mg | 1 mg | $64.778 OPPS | 48 | — | — |
| J9256 | Injection, nipocalimab-aahu, 3 mg | 3 MG | $32.321 | 1500 | — | — |
| J9260 | Injection, methotrexate sodium, 50 mg | 50 MG | $2.909 | 400 | — | yes |
| J9261 | Injection, nelarabine, 50 mg | 50 MG | $40.872 | 80 | — | — |
| J9263 | Injection, oxaliplatin, 0.5 mg | 0.5 MG | $0.087 | 700 | — | — |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 1 MG | $3.64 | 800 | — | yes |
| J9266 | Injection, pegaspargase, per single dose vial | 1 EA | $29,845.265 | 2 | — | — |
| J9267 | Injection, paclitaxel, 1 mg | 1 MG | $0.108 | 750 | — | yes |
| J9268 | Injection, pentostatin, 10 mg | 10 MG | $2,612.893 | 1 | — | — |
| J9269 | Injection, tagraxofusp-erzs, 10 micrograms | 10 MCG | $357.292 | 200 | — | — |
| J9271 | Injection, pembrolizumab, 1 mg | 1 MG | $62.253 | 400 | — | — |
| J9272 | Injection, dostarlimab-gxly, 10 mg | 10 MG | $250.548 | 100 | — | — |
| J9273 | Injection, tisotumab vedotin-tftv, 1 mg | 1 MG | $196.121 | 200 | — | — |
| J9274 | Injection, tebentafusp-tebn, 1 microgram | 1 MCG | $228.006 | 100 | — | — |
Show the other 7 codes on this page (pages not yet in search results)
- J7524 Mycophenolate mofetil, oral, 5 mg · limit $0.002
- J7526 Injection, mycophenolate mofetil, 5 mg · limit $0.20
- J7529 Mycophenolate mofetil, for suspension, oral, 5 mg · limit $0.034
- J7530 Mycophenolate mofetil (myhibbin), oral suspension, 5 mg · limit $0.115
- J9048 Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg · OPPS $6.97
- J9187 Injection, etoposide, 1 mg · limit $0.094
- J9192 Injection, fluorouracil, 10 mg · limit $0.039
How to read this page
The limit is the Medicare Part B payment allowance per billing unit for the October 2026 quarter, not per dose: divide the quantity administered by the unit in the descriptor to get the units billed, then multiply. Codes marked OPPS have no ASP limit and show the hospital outpatient rate per unit instead, and codes without a limit are priced by the contractor or carry a limit of zero in the CMS file. The MUE column is the practitioner Medically Unlikely Edit, the most units CMS expects on one date of service; the facility and supplier limits can differ and are on each code page. Column-2 pairs counts the active NCCI procedure-to-procedure edits in which the code is the bundled component, and Articles marks codes that a Medicare Administrative Contractor lists in a current billing and coding article.
Codes are listed in code order across 6 pages, and every code of the hub appears on exactly one of them. A code shown as text still has its own reference page with the same data; that page is kept out of search results because fewer CMS files join to the code, few people search for it, or its text is too close to another code's page, and the hub links the pages that are meant to be found. Amounts are Medicare national figures before locality and state adjustment.
Finding a code faster
Look up any code by number with the code search, or go back to the Drugs administered other than oral method, chemotherapy drugs (J codes) hub for its most searched codes and the answers to common questions. The MUE lookup shows every unit limit for a code, the NCCI edit checker tests whether two codes are bundled, and the HCPCS code lookup lists every range, drug and drug-class hub. For a drug you know by name, the J code index by drug name lists every code a generic or brand name bills under, and the ASP pricing file guide explains how the quarterly limits are set.
For teams evaluating QuickIntell software
Evaluate software for HCPCS coding workflows
Evaluating a recurring coding workflow? Review QuickCode for qualified coder review, documentation clarification and the billing handoff. Use your unit, modifier and edit questions to confirm the supported scope; a published CMS table does not establish an automated claim check.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
Disclaimer
Operational reference compiled from CMS publications. Amounts are Medicare national figures before locality and state adjustment; other payers differ. CPT codes appear as numbers only. This continuation page is kept out of search results; the hub and each code's own page are the pages meant to be found. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.